Effectiveness and safety of sofosbuvir plus ribavirin for HCV genotype 2 patients 65 and over with or without cirrhosis. (Q40478943)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effectiveness and safety of sofosbuvir plus ribavirin for HCV genotype 2 patients 65 and over with or without cirrhosis. |
scientific article |
Statements
1 reference
Effectiveness and safety of sofosbuvir plus ribavirin for HCV genotype 2 patients 65 and over with or without cirrhosis. (English)
1 reference
Eiichi Ogawa
1 reference
Norihiro Furusyo
1 reference
Hideyuki Nomura
1 reference
Kazuhiro Takahashi
1 reference
Nobuhiko Higashi
1 reference
Akira Kawano
1 reference
Kazufumi Dohmen
1 reference
Takeaki Satoh
1 reference
Koichi Azuma
1 reference
Makoto Nakamuta
1 reference
Toshimasa Koyanagi
1 reference
Masaki Kato
1 reference
Shinji Shimoda
1 reference
Eiji Kajiwara
1 reference
Jun Hayashi
1 reference
Kyushu University Liver Disease Study (KULDS) Group
1 reference
24 October 2016
1 reference
1 reference
136
1 reference
37-44
1 reference
Identifiers
1 reference
1 reference